Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines

详细信息    查看全文

• 作者：Maryam Beigom Mobasheri ; Reza Shirkoohi ; Kazem Zendehdel ; Issa Jahanzad…
• 关键词：TEX101 ; AURKC ; DAZ1 ; Breast cancer ; Immunotherapy ; Targeted therapy ; Cancer/testis genes ; Breast cancer cell lines
• 刊名：Tumor Biology
• 出版年：2015
• 出版时间：September 2015
• 年：2015
• 卷：36
• 期：10
• 页码：8201-8206
• 全文大小：288 KB
• 参考文献：1.Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10-9.CrossRef PubMed
  2.Saini S, Jagadish N, Gupta A, Bhatnagar A, Suri A. A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer. PLoS One. 2013;8(2):e57095.PubMed Central CrossRef PubMed
  3.Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, et al. Update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287-12.CrossRef PubMed
  4.Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5(8):615-5.CrossRef PubMed
  5.Ghafouri-Fard S, Modarressi MH. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med. 2009;12(4):395-04.PubMed
  6.Kelly RJ, Giaccone G. Lung cancer vaccines. Cancer J. 2011;17(5):302-.PubMed Central CrossRef PubMed
  7.Hunder NN, Wallen H, Cao J, Hendricks DW, Reilly JZ, Rodmyre R, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med. 2008;358:2698-03.PubMed Central CrossRef PubMed
  8.Krishnadas DK, Shapiro T, Lucas K. Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma. Pediatrics. 2013;131(1):336-1.CrossRef
  9.Chiriva-Internati M, Cobos E, Da Silva DM, Kast WM. Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines. Cancer Immun. 2008;24:8-.
  10.Whitehurst AW. Cause and consequence of cancer/testis antigen activation in cancer. Annu Rev Pharmacol Toxicol. 2014;54:251-2.CrossRef PubMed
  11.Ghafouri-Fard S, Shamsi R, Seifi-Alan M, Javaheri M, Tabarestani S. Cancer-testis genes as candidates for immunotherapy in breast cancer. Immunotherapy. 2014;6(2):165-9.CrossRef PubMed
  12.Katayama H, Sen S. Aurora kinase inhibitors as anticancer molecules. Biochim Biophys Acta. 2010;1799(20863917):829-9.PubMed Central CrossRef PubMed
  13.Zekri A, Lesan V, Ghaffari SH, Tabrizi MH, Modarressi MH. Gene amplification and overexpression of Aurora-C in breast and prostate cancer cell lines. Oncol Res. 2012;20(5-6):241-0.CrossRef PubMed
  14.Yin L, Chung CM, Huo R, Liu H, Zhou C, Xu W, et al. A sperm GPI-anchored protein elicits sperm-cumulus cross-talk leading to the acrosome reaction. Cell Mol Life Sci. 2009;66(5):900-.CrossRef PubMed
  15.Ghafouri-Fard S, Abbasi A, Moslehi H, Faramarzi N, Taba Taba Vakili S, Mobasheri MB, et al. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Cancer Detect Prev. 2007;31(4):296-02.CrossRef
  16.Ghafouri-Fard S, Modarressi MH, Yazarloo F. Expression of testis-specific genes, TEX101 and ODF4, in chronic myeloid leukemia and evaluation of TEX101 immunogenicity. Ann Saudi Med. 2012;32(3):256-1.PubMed
  17.Aarabi M, Saliminejad K, Sadeghi MR, Soltanghoraee H, Amirjannati N, Modarressi MH. Deletion and testicular expression of DAZ (deleted in azoospermia) gene in patients with non-obstructive azoospermia. Iranian J Public Health. 2009;38(3):17-3.
  18.Pfaff MW, Horgan GW, Dempfle L. Relative expression software toll (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acid Res. 2002;30:6.CrossRef
  19.Tsou JH, Chang KC, Chang-Liao PY, Yang ST, Lee CT, Chen YP, et al. Aberrantly expressed AURKC enhances the transformation and tumourigenicity of epithelial cells. J Pathol. 2011;225(2):243-4.CrossRef PubMed
  20.Goldenson B, Crispino JD. Oncogene. 2015;34(5):537-5.PubMed Central CrossRef PubMed
  21.Ulisse S, Arlot-Bonnemains Y, Baldini E, Morrone S, Carocci S, Di Luigi L, et al. Inhibition of the aurora kinases suppresses in vitro NT2-D1 cell growth and tumorigenicity. J Endocrinol. 2010;204(2):135-2.CrossRef PubMed
  22.Yazarloo F, Shirkoohi R, Mobasheri MB, Emami A, Modarressi MH. Expression analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: a gender-dependent expression pattern. Med Oncol. 2013;30(1):368.CrossRef PubMed
  23.Kalous O, Conklin D, Desai AJ, Dering J, Goldstein J, Ginther C, et al. AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53. Breast Cancer Res Treat. 2013;141(3):397-08.CrossRef PubMed
  24.Dianatpour M, Mehdipour P, Nayernia K, Mobasheri MB, Ghafouri-Fard S, Savad S, et al. Expression of testis specific genes TSGA10, TEX101 and ODF3 in breast cancer. Iran Red Crescent Med J. 2012;14(11):722-.PubMed Central CrossRef PubMed
  25.Miryounesi M, Nayernia K, Mobasheri MB, Dianatpour M, Oko R, Savad S, et al. Evaluation of in vitro spermatogenesis system effectiveness to study genes behavior: monitoring the expression of the testis specific 10 (Tsga10) gene as a model. Arch Iran Med. 2014;17
• 作者单位：Maryam Beigom Mobasheri (1) (2)
  Reza Shirkoohi (1)
  Kazem Zendehdel (1)
  Issa Jahanzad (3)
  Saeid Talebi (2)
  Mandana Afsharpad (1)
  Mohammad Hossein Modarressi (1) (2)
  
  1. Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. Department of Pathology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  
• 刊物主题：Cancer Research;
• 出版者：Springer Netherlands
• ISSN：1423-0380

文摘

Breast cancer is the most frequent cancer with second mortality rate in women worldwide. Lack of validated biomarkers for early detection of breast cancer to warranty the diagnosis and effective treatments in early stages has directed to the new therapeutic approach. Cancer/testis antigens which have restricted normal expression in testis and aberrant expression in different cancers are promising targets for generating cancer vaccines, monoclonal antibodies, or dendritic cell-based immunotherapy. In this context, we investigated the expression of two known cancer testis genes, Aurora kinase C (AURKC) and testis expressed 101 (TEX101), and one new candidate, deleted in azoospermia 1 (DAZ1), in six breast cancer cell lines including two ductal carcinomas, T47D and BT-474, and four adenocarcinomas, MDA-MB-231, MDA-MB-468, MCF7, and SKBR3 as well as 50 breast cancer tumors in comparison to normal mammary epithelial cells using quantitative real-time reverse transcription PCR (RT-PCR). Results showed significant overexpression (p--.000) of all three genes in BT474, DAZ1 in MDA-MB-231, and AURKC and DAZ1 in SKBR3 and significant downregulation (p--.000) of AURKC in MCF7 cell line relative to normal breast epithelial cells. Breast tumors showed significant overexpression of AURKC in comparison to normal breast tissues (p--.016). The results are noticeable especially in the case of AURKC; however, there is a little knowledge about the nature, causes, consequences, and effects of cancer/testis antigens activation in different cancers. It is suggested that AURKC has effects on cell division via its serin/threonin kinases activity and organizing microtubules in relation to centrosome/spindle function during mitosis. Keywords TEX101 AURKC DAZ1 Breast cancer Immunotherapy Targeted therapy Cancer/testis genes Breast cancer cell lines